Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.23.3
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2023
NET LOSS PER SHARE  
Schedule of Net Loss Per Share, Basic and Diluted

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands, except per share amounts)

2023

    

2022

    

2023

    

2022

Numerator for basic and diluted net loss per share:

  

 

  

  

 

  

Net loss

$

(46,373)

$

(60,774)

$

(148,742)

$

(427,990)

Denominator for basic and diluted net loss per share:

 

  

 

  

 

  

 

  

Weighted-average shares

 

323,188

 

316,008

 

321,328

 

313,902

Net loss per share—Basic and Diluted

$

(0.14)

$

(0.19)

$

(0.46)

$

(1.36)

Schedule of antidilutive securities excluded from computation of earnings per share The Company excluded the following potential common shares, presented based on amounts outstanding as of September 30, 2023 and 2022, from the computation of diluted net loss per share attributable to common stockholders because including them would have an anti-dilutive effect (in thousands):

Nine Months Ended September 30, 

2023

    

2022

Common Stock options outstanding

6,291

9,020

Unvested restricted stock units outstanding

25,482

19,032

Unvested restricted stock awards outstanding

17

123

6.0% Convertible Senior Notes due 2027

86,466

86,466

Total shares

118,256

114,641